[3-Azaniumyl-1-hydroxy-1-[hydroxy(oxido)phosphoryl]propyl]-hydroxyphosphinate (BioDeep_00000898885)
代谢物信息卡片
[3-Azaniumyl-1-hydroxy-1-[hydroxy(oxido)phosphoryl]propyl]-hydroxyphosphinate
化学式: C3H10NO7P2- (233.99325100000001)
中文名称:
谱图信息:
最多检出来源 () 0%
分子结构信息
SMILES: C(C[NH3+])C(O)(P(=O)(O)[O-])P(=O)(O)[O-]
InChI: InChI=1S/C3H11NO7P2/c4-2-1-3(5,12(6,7)8)13(9,10)11/h5H,1-2,4H2,(H2,6,7,8)(H2,9,10,11)/p-1
描述信息
D050071 - Bone Density Conservation Agents > D004164 - Diphosphonates
同义名列表
相关代谢途径
Reactome(0)
BioCyc(4)
PlantCyc(0)
代谢反应
0 个相关的代谢反应过程信息。
Reactome(0)
BioCyc(0)
WikiPathways(0)
Plant Reactome(0)
INOH(0)
PlantCyc(0)
COVID-19 Disease Map(0)
PathBank(0)
PharmGKB(0)
0 个相关的物种来源信息
在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：
- PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
- NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
- Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
- Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。
点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。
文献列表
- Kun Huang, Xiao Tang, Fang Tang. Combined chemotherapy of zoledronic acid and pamidronate in the treatment of bone metastases from nonsmall cell lung cancer and the effects on pain stress and bone metabolic indices.
Drug development research.
2024 Feb; 85(1):e22147. doi:
10.1002/ddr.22147. [PMID: 38349271] - Rachel Shulman, Abdallah S Geara, Jeffrey S Berns. Pamidronate versus zoledronic acid for the treatment of multiple myeloma-related hypercalcemia.
Kidney international.
2022 05; 101(5):1086. doi:
10.1016/j.kint.2021.12.033. [PMID: 35461601] - C Tanné, J-P Pracros, F Dijoud, P-Y Mure, F Bordet, A Duncan, J Bacchetta. Severe neonatal hypercalcemia revealing congenital mesoblastic nephroma: A case report and management of neonatal hypercalcemia: Severe neonatal hypercalcemia revealing congenital mesoblastic nephroma.
Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.
2022 Feb; 29(2):153-156. doi:
10.1016/j.arcped.2021.11.013. [PMID: 35039190] - Rachel Chava Rosenblum, Orit Twito, Liat Barzilay-Yoseph, Erez Ramaty, Noa Klein, Pnina Rotman-Pikielny. Efficacy and Safety of Intravenous Pamidronate for Parathyroid Hormone-dependent Hypercalcemia in Hospitalized Patients.
The Journal of clinical endocrinology and metabolism.
2021 10; 106(11):e4593-e4602. doi:
10.1210/clinem/dgab457. [PMID: 34157125] - Camiel de Roij van Zuijdewijn, Wim van Dorp, Sandrine Florquin, Joris Roelofs, Kees Verburgh. Bisphosphonate nephropathy: A case series and review of the literature.
British journal of clinical pharmacology.
2021 09; 87(9):3485-3491. doi:
10.1111/bcp.14780. [PMID: 33595131] - Pauliina Utriainen, Tuukka T Niinimäki, Anu J Huurre, Kaisa L Vepsäläinen, Outi M Mäkitie, Riitta A Niinimäki. Bisphosphonate treatment in children with acute lymphoblastic leukemia and osteonecrosis - radiological and clinical findings in a national cohort.
Acta oncologica (Stockholm, Sweden).
2021 Sep; 60(9):1140-1145. doi:
10.1080/0284186x.2021.1950928. [PMID: 34309491] - Sarah J Norman, David J Reeves, Lindsay M Saum. Use of Pamidronate for Hypercalcemia of Malignancy in Renal Dysfunction.
Journal of pharmacy practice.
2021 Aug; 34(4):553-557. doi:
10.1177/0897190019883162. [PMID: 31648595] - Hongqin You, Guanglei Dang, Bichao Lu, Siya Zhang, Chen Li, Lun Wang, Yu Hu, Hui Chen, Jianmin Zhang, Wei He. Serum Sp17 Autoantibody Serves as a Potential Specific Biomarker in Patients with SAPHO Syndrome.
Journal of clinical immunology.
2021 04; 41(3):565-575. doi:
10.1007/s10875-020-00937-w. [PMID: 33392854] - Nan Wu, Yanxue Zhao, Weilan Tao, Zhihong Wu, Chen Li, Li Li. A single cohort, open-label study of the efficacy of pamidronate for palmoplantar pustulosis in synovitis, acne, pustulosis, hyperostosis and osteitis (SAPHO) syndrome.
Clinical and experimental rheumatology.
2020 Nov; 38(6):1263-1264. doi:
". [PMID: 32573425] - Gordon L Klein. Burn injury and restoration of muscle function.
Bone.
2020 03; 132(?):115194. doi:
10.1016/j.bone.2019.115194. [PMID: 31863962] - Elen de Souza Tolentino, Tamara F de Castro, Felipe C Michellon, Ana C C Passoni, Lorena J A Ortega, Lilian C V Iwaki, Mariliani C da Silva. Adjuvant therapies in the management of medication-related osteonecrosis of the jaws: Systematic review.
Head & neck.
2019 12; 41(12):4209-4228. doi:
10.1002/hed.25944. [PMID: 31502752] - Medha Satyarengga, Kristi D Silver. Severe hypercalcaemia due to household cleaner ingestion.
BMJ case reports.
2019 Oct; 12(10):. doi:
10.1136/bcr-2019-231771. [PMID: 31666255] - Sophie Kim. A case of severe, irreversible hypocalcemia after one dose of pamidronate administered for hypercalcemia of malignancy.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.
2019 Oct; 25(7):1787-1793. doi:
10.1177/1078155218812945. [PMID: 30419769] - Carlo Massimetti, Antonio Bellasi, Antonio Modoni, Vito Gomes, Sandro Feriozzi. Multifaceted approach to a rare clinical case of calciphylaxis in a renal transplant recipient.
Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia.
2019 Sep; 36(5):. doi:
NULL. [PMID: 31580546] - Korcan Demir, Hakan Döneray, Cengiz Kara, Zeynep Atay, Semra Çetinkaya, Atilla Çayır, Ahmet Anık, Erdal Eren, Ahmet Uçaktürk, Gülay Can Yılmaz, Ayça Törel Ergür, Mustafa Kendirci, Zehra Aycan, Abdullah Bereket, Murat Aydın, Zerrin Orbak, Behzat Özkan. Comparison of Treatment Regimens in Management of Severe Hypercalcemia Due to Vitamin D Intoxication in Children.
Journal of clinical research in pediatric endocrinology.
2019 05; 11(2):140-148. doi:
10.4274/jcrpe.galenos.2018.2018.0131. [PMID: 30396880] - Jane Rigg, Elise Gilbertson, Helen L Barrett, Fiona L Britten, Karin Lust. Primary Hyperparathyroidism in Pregnancy: Maternofetal Outcomes at a Quaternary Referral Obstetric Hospital, 2000 Through 2015.
The Journal of clinical endocrinology and metabolism.
2019 03; 104(3):721-729. doi:
10.1210/jc.2018-01104. [PMID: 30247615] - Siyang Leng, Yizhen Chen, Wei-Yann Tsai, Divaya Bhutani, Grace C Hillyer, Emerson Lim, Melissa K Accordino, Jason D Wright, Dawn L Hershman, Suzanne Lentzsch, Alfred I Neugut. Use of Bisphosphonates in Elderly Patients With Newly Diagnosed Multiple Myeloma.
Journal of the National Comprehensive Cancer Network : JNCCN.
2019 01; 17(1):22-28. doi:
10.6004/jnccn.2018.7079. [PMID: 30659126] - Jawed Akhtar, Vijaya Kumar Gorantla, Peter D Snell, Barry M Wall. Acute esophageal necrosis (black esophagus) complicating calcific uremic arteriolopathy
.
Clinical nephrology.
2019 Jan; 91(1):48-51. doi:
10.5414/cn109470. [PMID: 30415652] - Sonia Fernández Cañabate, Cristina Lucas Alvarez, Luis Ortega Valin, Jorge Estifan Ksabji. Sodium thiosulfate and pamidronate for treatment of calciphylaxis: case report.
Colombia medica (Cali, Colombia).
2018 Dec; 49(4):288-291. doi:
10.25100/cm.v49i3.4134. [PMID: 30700922] - Sara Mahmoud, Hassan Mitwally, Hani Soliman El Zeer, Ihab El Madhoun, Mohamad Khatib. Use of Pamidronate to Treat Hypercalcemia in an Oncology Dialysis Patient: A Case Report.
The American journal of case reports.
2018 Sep; 19(?):1087-1089. doi:
10.12659/ajcr.908605. [PMID: 30209247] - Helena Florez, Stanislava Mandelikova, Xavier Filella, Ana Monegal, Núria Guañabens, Pilar Peris. Clinical significance of increased serum levels of FGF-23 in fibrous dysplasia.
Medicina clinica.
2018 07; 151(2):65-67. doi:
10.1016/j.medcli.2017.11.036. [PMID: 29295788] - Anna B Basok, Boris Rogachev, Yosef Shmuel Haviv, Marina Vorobiov. Treatment of extreme hypercalcaemia: the role of haemodialysis.
BMJ case reports.
2018 Jun; 2018(?):. doi:
10.1136/bcr-2017-223772. [PMID: 29866671] - Funda Baştuğ, Hülya Nalçacıoğlu, Veysel Nijat Baş, Binnaz Tekatlı-Çelik, Hasan Çetinkaya, Sibel Yel. Acute renal failure due to severe hypercalcemia and nephrocalcinosis treated with two doses of pamidronate in an infant with Williams-Beuren syndrome.
The Turkish journal of pediatrics.
2018; 60(2):210-215. doi:
10.24953/turkjped.2018.02.017. [PMID: 30325132] - Nishank Jain, Robert F Reilly. Hungry bone syndrome.
Current opinion in nephrology and hypertension.
2017 07; 26(4):250-255. doi:
10.1097/mnh.0000000000000327. [PMID: 28375869] - Adriano L Spirlandeli, Ingrid Dick-de-Paula, Ariane Zamarioli, Vanda Jorgetti, Leandra N Z Ramalho, Marcello H Nogueira-Barbosa, Jose B Volpon, Alceu A Jordão, Fernando Q Cunha, Sandra Y Fukada, Francisco J A de Paula. Hepatic Osteodystrophy: The Mechanism of Bone Loss in Hepatocellular Disease and the Effects of Pamidronate Treatment.
Clinics (Sao Paulo, Brazil).
2017 Apr; 72(4):231-237. doi:
10.6061/clinics/2017(04)07. [PMID: 28492723] - Anne-Sophie Lambert, Anya Rothenbuhler, Perrine Charles, Sylvie Brailly-Tabard, Séverine Trabado, Elisabeth Célestin, Emmanuel Durand, Isabelle Fontaine, Lotfi Miladi, Philippe Wicart, Nadia Bahi-Buisson, Agnès Linglart. Lower incidence of fracture after IV bisphosphonates in girls with Rett syndrome and severe bone fragility.
PloS one.
2017; 12(10):e0186941. doi:
10.1371/journal.pone.0186941. [PMID: 29073271] - Cengiz Kara, Semra Çetinkaya, Suzan Gündüz, Gülay Can Yılmaz, Zehra Aycan, Murat Aydın. Efficacy and safety of pamidronate in children with vitamin D intoxication.
Pediatrics international : official journal of the Japan Pediatric Society.
2016 Jul; 58(7):562-8. doi:
10.1111/ped.12875. [PMID: 26646324] - Rifka C Schulman, Erin L Moshier, Lisa Rho, Martin F Casey, James H Godbold, Mone Zaidi, Jeffrey I Mechanick. INTRAVENOUS PAMIDRONATE IS ASSOCIATED WITH REDUCED MORTALITY IN PATIENTS WITH CHRONIC CRITICAL ILLNESS.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
2016 Jul; 22(7):799-808. doi:
10.4158/ep151050.or. [PMID: 26919649] - Ryota Tanaka, Kan Yonemori, Akihiro Hirakawa, Fumie Kinoshita, Naoki Takahashi, Jun Hashimoto, Makoto Kodaira, Harukaze Yamamoto, Mayu Yunokawa, Chikako Shimizu, Manabu Fujimoto, Yasuhiro Fujiwara, Kenji Tamura. Risk Factors for Developing Skeletal-Related Events in Breast Cancer Patients With Bone Metastases Undergoing Treatment With Bone-Modifying Agents.
The oncologist.
2016 Apr; 21(4):508-13. doi:
10.1634/theoncologist.2015-0377. [PMID: 26975863] - Telma Palomo, Maria C Andrade, Barbara S E Peters, Fernanda A Reis, João Tomás A Carvalhaes, Francis H Glorieux, Frank Rauch, Marise Lazaretti-Castro. Evaluation of a Modified Pamidronate Protocol for the Treatment of Osteogenesis Imperfecta.
Calcified tissue international.
2016 Jan; 98(1):42-8. doi:
10.1007/s00223-015-0061-y. [PMID: 26387692] - R Nicole Howie, Maryka Bhattacharyya, Mohamed E Salama, Mona El Refaey, Carlos Isales, James Borke, Asma Daoudi, Fardous Medani, Mohammed E Elsalanty. Removal of pamidronate from bone in rats using systemic and local chelation.
Archives of oral biology.
2015 Dec; 60(12):1699-707. doi:
10.1016/j.archoralbio.2015.09.001. [PMID: 26431826] - Gordon L Klein, David N Herndon, Phuong T Le, Clark R Andersen, Debra Benjamin, Clifford J Rosen. The effect of burn on serum concentrations of sclerostin and FGF23.
Burns : journal of the International Society for Burn Injuries.
2015 Nov; 41(7):1532-5. doi:
10.1016/j.burns.2015.04.001. [PMID: 25922302] - Tatjana I Gabbert, Bodo Hoffmeister, Dieter Felsenberg. Risk factors influencing the duration of treatment with bisphosphonates until occurrence of an osteonecrosis of the jaw in 963 cancer patients.
Journal of cancer research and clinical oncology.
2015 Apr; 141(4):749-58. doi:
10.1007/s00432-014-1853-6. [PMID: 25319961] - Shahrzad Shahidi, Farzaneh Ashrafi, Morteza Mohammadi, Firoozeh Moeinzadeh, Abdolamir Atapour. Low-dose pamidronate for treatment of early bone loss following kidney transplantation: a randomized controlled trial.
Iranian journal of kidney diseases.
2015 Jan; 9(1):50-5. doi:
. [PMID: 25599737] - Nakysa Hooman, Rama Naghshi-Zadiyan, Mitra Mehrazma, Fariba Jahangiri. Successful treatment of calciphylaxis with pamidronate.
Iranian journal of kidney diseases.
2015 Jan; 9(1):67-70. doi:
NULL. [PMID: 25599740] - Michael P Whyte, Katherine L Madson, Steven Mumm, William H McAlister, Deborah V Novack, Jo C Blair, Timothy R Helliwell, Marina Stolina, Laurence J Abernethy, Nicholas J Shaw. Rapid skeletal turnover in a radiographic mimic of osteopetrosis.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
2014 Dec; 29(12):2601-9. doi:
10.1002/jbmr.2289. [PMID: 24919763] - Rana R McKay, Xun Lin, Julia J Perkins, Daniel Y C Heng, Ronit Simantov, Toni K Choueiri. Prognostic significance of bone metastases and bisphosphonate therapy in patients with renal cell carcinoma.
European urology.
2014 Sep; 66(3):502-9. doi:
10.1016/j.eururo.2014.02.040. [PMID: 24613250] - Chirayu G Patel, Andrew J Yee, Tyler A Scullen, Neeharika Nemani, Loredana Santo, Paul G Richardson, Jacob P Laubach, Irene M Ghobrial, Robert L Schlossman, Nikhil C Munshi, Kenneth C Anderson, Noopur S Raje. Biomarkers of bone remodeling in multiple myeloma patients to tailor bisphosphonate therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2014 Aug; 20(15):3955-61. doi:
10.1158/1078-0432.ccr-14-0434. [PMID: 24958808] - Anke L L Lameris, Christel L M Geesing, Joost G J Hoenderop, Michiel F Schreuder. Importance of dietary calcium and vitamin D in the treatment of hypercalcaemia in Williams-Beuren syndrome.
Journal of pediatric endocrinology & metabolism : JPEM.
2014 Jul; 27(7-8):757-61. doi:
10.1515/jpem-2013-0229. [PMID: 24572979] - Christina L Addison, Nathaniel Bouganim, John Hilton, Lisa Vandermeer, Susan Dent, Eitan Amir, Sean Hopkins, Iryna Kuchuk, Roanne Segal, Xinni Song, Stan Gertler, Sasha Mazzarello, George Dranitsaris, Daylily Ooi, Gregory Pond, Mark Clemons. A phase II, multicentre trial evaluating the efficacy of de-escalated bisphosphonate therapy in metastatic breast cancer patients at low-risk of skeletal-related events.
Breast cancer research and treatment.
2014 Apr; 144(3):615-24. doi:
10.1007/s10549-014-2906-x. [PMID: 24638849] - Noah M Hahn, Constantin T Yiannoutsos, Kristina Kirkpatrick, Jaya Sharma, Christopher J Sweeney. Failure to suppress markers of bone turnover on first-line hormone therapy for metastatic prostate cancer is associated with shorter time to skeletal-related event.
Clinical genitourinary cancer.
2014 Feb; 12(1):33-40.e4. doi:
10.1016/j.clgc.2013.07.002. [PMID: 24126237] - Patrick Reagan, Antonello Pani, Mitchell H Rosner. Approach to diagnosis and treatment of hypercalcemia in a patient with malignancy.
American journal of kidney diseases : the official journal of the National Kidney Foundation.
2014 Jan; 63(1):141-7. doi:
10.1053/j.ajkd.2013.06.025. [PMID: 24021907] - Kai Sen Tan, Wai Chii Ng, Ju Ee Seet, Farzad Olfat, Bevin P Engelward, Vincent T K Chow. Investigating the efficacy of pamidronate, a chemical inhibitor of farnesyl pyrophosphate synthase, in the inhibition of influenza virus infection in vitro and in vivo.
Molecular medicine reports.
2014 Jan; 9(1):51-6. doi:
10.3892/mmr.2013.1750. [PMID: 24154548] - Zijie Wang, Zhijian Han, Jun Tao, Pei Lu, Xuzhong Liu, Jun Wang, Bian Wu, Zhengkai Huang, Changjun Yin, Ruoyun Tan, Min Gu. Clinical efficacy and safety of pamidronate therapy on bone mass density in early post-renal transplant period: a meta-analysis of randomized controlled trials.
PloS one.
2014; 9(9):e108106. doi:
10.1371/journal.pone.0108106. [PMID: 25265508] - Shafic Said Al-Nammari, Theologis Timothy, Sabokbar Afsie. A Surgeon's guide to advances in the pharmacological management of acute Charcot neuroarthropathy.
Foot and ankle surgery : official journal of the European Society of Foot and Ankle Surgeons.
2013 Dec; 19(4):212-7. doi:
10.1016/j.fas.2013.06.011. [PMID: 24095226] - M P Yavropoulou, N A T Hamdy, S E Papapoulos. Long-term treatment of osteoporotic women with bisphosphonates does not impair the response to subsequently administered intravenous pamidronate.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA.
2013 Aug; 24(8):2353-7. doi:
10.1007/s00198-013-2301-1. [PMID: 23436076] - Forough Saki, Zohreh Karamizadeh, Shiva Nasirabadi, Steven Mumm, William H McAlister, Michael P Whyte. Juvenile paget's disease in an Iranian kindred with vitamin D deficiency and novel homozygous TNFRSF11B mutation.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
2013 Jun; 28(6):1501-8. doi:
10.1002/jbmr.1868. [PMID: 23322328] - Sylva Skalova, Lucie Cerna, Milan Bayer, Stepan Kutilek, Martin Konrad, Karl-Peter Schlingmann. Intravenous pamidronate in the treatment of severe idiopathic infantile hypercalcemia.
Iranian journal of kidney diseases.
2013 Mar; 7(2):160-4. doi:
. [PMID: 23485543] - Nakysa Hooman. Bisphosphonates for treatment of severe idiopathic infantile hypercalcemia.
Iranian journal of kidney diseases.
2013 Mar; 7(2):79-81. doi:
NULL. [PMID: 23485530] - Parish P Sedghizadeh, Allan C Jones, Chris LaVallee, Roger W Jelliffe, Anh D Le, Peter Lee, Andrew Kiss, Michael Neely. Population pharmacokinetic and pharmacodynamic modeling for assessing risk of bisphosphonate-related osteonecrosis of the jaw.
Oral surgery, oral medicine, oral pathology and oral radiology.
2013 Feb; 115(2):224-32. doi:
10.1016/j.oooo.2012.08.455. [PMID: 23246224] - Alexandre Loupy, Suresh Krishna Ramakrishnan, Bharath Wootla, Régine Chambrey, Renaud de la Faille, Soline Bourgeois, Patrick Bruneval, Chantal Mandet, Erik Ilso Christensen, Hélène Faure, Lydie Cheval, Kamel Laghmani, Corinne Collet, Dominique Eladari, Robert H Dodd, Martial Ruat, Pascal Houillier. PTH-independent regulation of blood calcium concentration by the calcium-sensing receptor.
The Journal of clinical investigation.
2012 Sep; 122(9):3355-67. doi:
10.1172/jci57407. [PMID: 22886306] - Raimund Hirschberg. Renal complications from bisphosphonate treatment.
Current opinion in supportive and palliative care.
2012 Sep; 6(3):342-7. doi:
10.1097/spc.0b013e328356062e. [PMID: 22710581] - Feng Xie, Rob Hopkins, Natasha Burke, Jean-Eric Tarride, Ron Goeree. Patient management, and time and health care resource utilization associated with the use of intravenous bisphosphonates for patients with metastatic bone disease: a Delphi study.
Hospital practice (1995).
2012 Apr; 40(2):131-7. doi:
10.3810/hp.2012.04.978. [PMID: 22615087] - Yu Chen, Yuxiu Liu, Zhidong Chen, Meilan Chen, Yan Zhu. [Simultaneous determination of alendronate, pamidronate, ibandronate and risedronate using ion chromatography with integrated pulsed amperometric detection].
Se pu = Chinese journal of chromatography.
2012 Apr; 30(4):414-8. doi:
10.3724/sp.j.1123.2011.12070. [PMID: 22799202] - Demin Liu, Stephanie A Kramer, Rachel C Huxford-Phillips, Shunzhi Wang, Joseph Della Rocca, Wenbin Lin. Coercing bisphosphonates to kill cancer cells with nanoscale coordination polymers.
Chemical communications (Cambridge, England).
2012 Mar; 48(21):2668-70. doi:
10.1039/c2cc17635a. [PMID: 22428170] - V Coviello, F Peluso, S Z Dehkhargani, F Verdugo, L Raffaelli, P F Manicone, A D' Addona. Platelet-rich plasma improves wound healing in multiple myeloma bisphosphonate-associated osteonecrosis of the jaw patients.
Journal of biological regulators and homeostatic agents.
2012 Jan; 26(1):151-5. doi:
NULL. [PMID: 22475108] - Chung-Yu Huang, Cai-Mei Zheng, Chia-Chao Wu, Lan Lo, Kuo-Cheng Lu, Pauling Chu. Effects of pamidronate and calcitriol on the set point of the parathyroid gland in postmenopausal hemodialysis patients with secondary hyperparathyroidism.
Nephron. Clinical practice.
2012; 122(3-4):93-101. doi:
10.1159/000350431. [PMID: 23635416] - M A G J ten Dam, L B Hilbrands, J F M Wetzels. Nephrotic syndrome induced by pamidronate.
Medical oncology (Northwood, London, England).
2011 Dec; 28(4):1196-200. doi:
10.1007/s12032-010-9628-7. [PMID: 20865462] - Bita Omidvar, Ali Ghorbani, Heshmatollah Shahbazian, Seyed Seifollah Beladi Mousavi, Seyed Javad Shariat Nabavi, Mohammad Alasti. Comparison of alendronate and pamidronate on bone loss in kidney transplant patients for the first 6 months of transplantation.
Iranian journal of kidney diseases.
2011 Nov; 5(6):420-4. doi:
. [PMID: 22057076] - Taichi Kitaoka, Noriyuki Namba, Kohji Miura, Takuo Kubota, Yasuhisa Ohata, Makoto Fujiwara, Haruhiko Hirai, Takehisa Yamamoto, Keiichi Ozono. Decrease in serum FGF23 levels after intravenous infusion of pamidronate in patients with osteogenesis imperfecta.
Journal of bone and mineral metabolism.
2011 Sep; 29(5):598-605. doi:
10.1007/s00774-011-0262-z. [PMID: 21344299] - Luigi Cella, Aldo Oppici, Mariacristina Arbasi, Mauro Moretto, Massimo Piepoli, Daniele Vallisa, Adriano Zangrandi, Camilla Di Nunzio, Luigi Cavanna. Autologous bone marrow stem cell intralesional transplantation repairing bisphosphonate related osteonecrosis of the jaw.
Head & face medicine.
2011 Aug; 7(?):16. doi:
10.1186/1746-160x-7-16. [PMID: 21849044] - Hiromichi Yoshizawa, Tetsu Akimoto, Katsuhiko Nishino, Makoto Inoue, Chiharu Ito, Shinichi Takeda, Atsushi Kotoda, Kaichiro Tamba, Wako Yumura, Shigeaki Muto, Yoshihiko Ueda, Eiji Kusano. Nephrotic syndrome and renal failure in a patient with metastatic breast cancer.
Clinical and experimental nephrology.
2011 Aug; 15(4):567-71. doi:
10.1007/s10157-011-0425-1. [PMID: 21416249] - Michel Laroche, Christina Livideanu, Carle Paul, Alain Cantagrel. Interferon alpha and pamidronate in osteoporosis with fracture secondary to mastocytosis.
The American journal of medicine.
2011 Aug; 124(8):776-8. doi:
10.1016/j.amjmed.2011.02.038. [PMID: 21787907] - Nikolas Harbord. Novel nephrotoxins.
Advances in chronic kidney disease.
2011 May; 18(3):214-8. doi:
10.1053/j.ackd.2010.12.001. [PMID: 21531328] - M Joerger, A Templeton, D Köberle, H Engler, W F Riesen, B Thürlimann. Procollagen type I N-propeptide is a predictor of skeletal morbidity in patients with malignant osteolytic bone disease on bisphosphonates.
Cancer chemotherapy and pharmacology.
2011 May; 67(5):1137-44. doi:
10.1007/s00280-010-1420-z. [PMID: 20683595] - Catherine H Van Poznak, Sarah Temin, Gary C Yee, Nora A Janjan, William E Barlow, J Sybil Biermann, Linda D Bosserman, Cindy Geoghegan, Bruce E Hillner, Richard L Theriault, Dan S Zuckerman, Jamie H Von Roenn. American Society of Clinical Oncology executive summary of the clinical practice guideline update on the role of bone-modifying agents in metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2011 Mar; 29(9):1221-7. doi:
10.1200/jco.2010.32.5209. [PMID: 21343561] - Hiroaki Shimizu, Tsuyoshi Monden, Takanori Tomotsune, Yuki Nakatani, Nozomi Domeki, Mihoko Matsumura, Teruo Jojima, Yoshiaki Kawagoe, Kikuo Kasai. A case of myeloma with hypercalcemia caused by high serum concentrations of both parathyroid hormone-related peptide (PTHrP) and macrophage inflammatory protein-1α (MIP-1α).
Internal medicine (Tokyo, Japan).
2011; 50(24):2993-6. doi:
10.2169/internalmedicine.50.6096. [PMID: 22185991] - J-V Torregrosa, D Fuster, A Monegal, M A Gentil, J Bravo, L Guirado, A Muxí, J Cubero. Efficacy of low doses of pamidronate in osteopenic patients administered in the early post-renal transplant.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA.
2011 Jan; 22(1):281-7. doi:
10.1007/s00198-010-1197-2. [PMID: 20229199] - Giorgio Graziani, Albania Calvetta, David Cucchiari, Serenella Valaperta, Alessandro Montanelli. Life-threatening hypercalcemia in patients with rhabdomyolysis-induced oliguric acute renal failure.
Journal of nephrology.
2011 Jan; 24(1):128-31. doi:
10.5301/jn.2010.5794. [PMID: 20954138] - Marius E Kraenzlin, Christian Graf, Christian Meier, Claude Kraenzlin, Niklaus F Friedrich. Possible beneficial effect of bisphosphonates in osteonecrosis of the knee.
Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA.
2010 Dec; 18(12):1638-44. doi:
10.1007/s00167-010-1106-4. [PMID: 20376625] - E Aström, P Magnusson, S Eksborg, S Söderhäll. Biochemical bone markers in the assessment and pamidronate treatment of children and adolescents with osteogenesis imperfecta.
Acta paediatrica (Oslo, Norway : 1992).
2010 Dec; 99(12):1834-40. doi:
10.1111/j.1651-2227.2010.01968.x. [PMID: 20726960] - Mark A Perazella, Gilbert W Moeckel. Nephrotoxicity from chemotherapeutic agents: clinical manifestations, pathobiology, and prevention/therapy.
Seminars in nephrology.
2010 Nov; 30(6):570-81. doi:
10.1016/j.semnephrol.2010.09.005. [PMID: 21146122] - Sylvie Dusilová Sulková, Martin Válek. Skin wounds associated with calciphylaxis in end-stage renal disease patients on dialysis.
Nutrition (Burbank, Los Angeles County, Calif.).
2010 Sep; 26(9):910-4. doi:
10.1016/j.nut.2010.01.018. [PMID: 20692603] - Mie Jin Lim, Seong Ryul Kwon, Shin-Goo Park, Won Park. Acute effects of intravenous administration of pamidronate in patients with osteoporosis.
Journal of Korean medical science.
2010 Sep; 25(9):1277-83. doi:
10.3346/jkms.2010.25.9.1277. [PMID: 20808669] - Ma Victoria Hernández, Pilar Peris, Ana Monegal, Raquel Reyes, Africa Muxi, Laia Gifre, Nuria Guañabens. Effects of intravenous pamidronate on renal function, bone mineral metabolism and bone mass in patients with severe osteoporosis.
The American journal of the medical sciences.
2010 Mar; 339(3):225-9. doi:
10.1097/maj.0b013e3181c7c89c. [PMID: 20220332] - Irene Mamkin, Pascal Philibert, Henry Anhalt, Svetlana Ten, Charles Sultan. Unusual phenotypical variations in a boy with McCune-Albright syndrome.
Hormone research in paediatrics.
2010; 73(3):215-22. doi:
10.1159/000284365. [PMID: 20197676] - F Sierra, E Román, C Barreda, M Moleón, J Pastor, A Navarro. [Effect of pamidronate infusion time on renal function in patients with multiple myeloma].
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria.
2010 Jan; 34(1):23-6. doi:
10.1016/j.farma.2009.09.003. [PMID: 20144818] - Jonathan McMahan, Travis Linneman. A case of resistant hypercalcemia of malignancy with a proposed treatment algorithm.
The Annals of pharmacotherapy.
2009 Sep; 43(9):1532-8. doi:
10.1345/aph.1l313. [PMID: 19622757] - Ogo Egbuna, Steven Quinn, Lakshmi Kantham, Robert Butters, Jiang Pang, Martin Pollak, David Goltzman, Edward Brown. The full-length calcium-sensing receptor dampens the calcemic response to 1alpha,25(OH)2 vitamin D3 in vivo independently of parathyroid hormone.
American journal of physiology. Renal physiology.
2009 Sep; 297(3):F720-8. doi:
10.1152/ajprenal.00164.2009. [PMID: 19474191] - Masahiko Nagahama, Domenic A Sica. Pamidronate-induced kidney injury in a patient with metastatic breast cancer.
The American journal of the medical sciences.
2009 Sep; 338(3):225-8. doi:
10.1097/maj.0b013e318184e741. [PMID: 19581797] - Jia-Woei Hou. Amelioration of hypophosphatemic rickets and osteoporosis with pamidronate and growth hormone in Lowe syndrome.
Journal of the Formosan Medical Association = Taiwan yi zhi.
2009 Sep; 108(9):730-5. doi:
10.1016/s0929-6646(09)60397-1. [PMID: 19773212] - Vivian Y Pao, Sandra Chang, Dolores M Shoback, Daniel D Bikle. Hypercalcemia and overexpression of CYP27B1 in a patient with nephrogenic systemic fibrosis: clinical vignette and literature review.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
2009 Jun; 24(6):1135-9. doi:
10.1359/jbmr.081261. [PMID: 19113910] - Stephen B Walsh, Paul Altmann, James Pattison, Martin Wilkie, Muhammad M Yaqoob, Christopher Dudley, Paul Cockwell, Paul Sweny, Linda M Banks, Margaret Hall-Craggs, Kate Noonan, Christopher Andrews, John Cunningham. Effect of pamidronate on bone loss after kidney transplantation: a randomized trial.
American journal of kidney diseases : the official journal of the National Kidney Foundation.
2009 May; 53(5):856-65. doi:
10.1053/j.ajkd.2008.11.036. [PMID: 19393473] - Tara C Brennan, René Rizzoli, Patrick Ammann. Selective modification of bone quality by PTH, pamidronate, or raloxifene.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
2009 May; 24(5):800-8. doi:
10.1359/jbmr.081227. [PMID: 19063681] - Lauren M Czosnowski, Joanna Q Hudson, Robert B Canada. Hypercalcemia associated with tertiary hyperparathyroidism managed conservatively with pamidronate in a hemodialysis patient.
The American journal of the medical sciences.
2009 Apr; 337(4):300-1. doi:
10.1097/maj.0b013e31818a84a5. [PMID: 19365180] - Valérie Jotterand, Solange Moll, Pierre-Yves Martin, Patrick Saudan. [Bisphosphonate-induced collapsing focal segmental glomerulosclerosis; two clinical cases and literature review].
Nephrologie & therapeutique.
2009 Apr; 5(2):134-8. doi:
10.1016/j.nephro.2008.08.013. [PMID: 19013118] - Ellen G Neven, Marc E De Broe, Patrick C D'Haese. Prevention of vascular calcification with bisphosphonates without affecting bone mineralization: a new challenge?.
Kidney international.
2009 Mar; 75(6):580-2. doi:
10.1038/ki.2008.663. [PMID: 19247382] - Koba A Lomashvili, Marie-Claude Monier-Faugere, Xiaonan Wang, Hartmut H Malluche, W Charles O'Neill. Effect of bisphosphonates on vascular calcification and bone metabolism in experimental renal failure.
Kidney international.
2009 Mar; 75(6):617-25. doi:
10.1038/ki.2008.646. [PMID: 19129793] - Ari Auron, Leyat Tal, Tarak Srivastava, Uri S Alon. Reversal of hypercalcemic acute kidney injury by treatment with intravenous bisphosphonates.
Pediatric nephrology (Berlin, Germany).
2009 Mar; 24(3):613-7. doi:
10.1007/s00467-008-1011-y. [PMID: 18839218] - Ana Monegal, Núria Guañabens, María Jesús Suárez, Francisco Suárez, Gerardo Clemente, Miguel García-González, Manuel De la Mata, Trinidad Serrano, Fernando Casafont, Santiago Tome, Santiago Torne, Cesar Barrios, Miquel Navasa. Pamidronate in the prevention of bone loss after liver transplantation: a randomized controlled trial.
Transplant international : official journal of the European Society for Organ Transplantation.
2009 Feb; 22(2):198-206. doi:
10.1111/j.1432-2277.2008.00763.x. [PMID: 18796000] - J J Brown, M R Zacharin. Safety and efficacy of intravenous zoledronic acid in paediatric osteoporosis.
Journal of pediatric endocrinology & metabolism : JPEM.
2009 Jan; 22(1):55-63. doi:
10.1515/jpem.2009.22.1.55. [PMID: 19344075] - T M Fan, S C Charney, L P de Lorimier, L D Garrett, D J Griffon, W J Gordon-Evans, J M Wypij. Double-blind placebo-controlled trial of adjuvant pamidronate with palliative radiotherapy and intravenous doxorubicin for canine appendicular osteosarcoma bone pain.
Journal of veterinary internal medicine.
2009 Jan; 23(1):152-60. doi:
10.1111/j.1939-1676.2008.0221.x. [PMID: 19175734] - M Alharbi, G Pinto, G Finidori, J C Souberbielle, F Guillou, S Gaubicher, M Le Merrer, M Polak. Pamidronate treatment of children with moderate-to-severe osteogenesis imperfecta: a note of caution.
Hormone research.
2009 Jan; 71(1):38-44. doi:
10.1159/000173740. [PMID: 19039235] - María Virginia Gangoiti, Ana María Cortizo, Verónica Arnol, Juan Ignacio Felice, Antonio Desmond McCarthy. Opposing effects of bisphosphonates and advanced glycation end-products on osteoblastic cells.
European journal of pharmacology.
2008 Dec; 600(1-3):140-7. doi:
10.1016/j.ejphar.2008.10.031. [PMID: 18973752] - Mark A Perazella, Glen S Markowitz. Bisphosphonate nephrotoxicity.
Kidney international.
2008 Dec; 74(11):1385-93. doi:
10.1038/ki.2008.356. [PMID: 18685574] - Elzbieta Jakubowska-Pietkiewicz, Danuta Chlebna-Sokół. New trends in the treatment of osteogenesis imperfecta type III - own experience.
Ortopedia, traumatologia, rehabilitacja.
2008 Nov; 10(6):593-601. doi:
NULL. [PMID: 19153548] - Justine Bacchetta, Roland Chapurlat, Raymonde Bouvier, Corinne Antignac, Laurence Dubourg, Rémi Kohler, Pierre D Delmas, Pierre Cochat. Nephronophthisis-like nephritis associated with fibrous dysplasia of bone.
Pediatric nephrology (Berlin, Germany).
2008 Sep; 23(9):1559-63. doi:
10.1007/s00467-008-0850-x. [PMID: 18512082] - Jarkko Jokihaara, Ilkka H Pörsti, Peeter Kööbi, Pasi M Jolma, Jukka T Mustonen, Heikki H T Saha, Harri Sievänen, Pekka Kannus, Urszula T Iwaniec, Russell T Turner, Teppo L N Järvinen. Treatment of experimental renal osteodystrophy with pamidronate.
Kidney international.
2008 Aug; 74(3):319-27. doi:
10.1038/ki.2008.180. [PMID: 18463610] - Atsushi Okada, Hiroshi Ohshima, Yasunori Itoh, Takahiro Yasui, Keiichi Tozawa, Kenjiro Kohri. Risk of renal stone formation induced by long-term bed rest could be decreased by premedication with bisphosphonate and increased by resistive exercise.
International journal of urology : official journal of the Japanese Urological Association.
2008 Jul; 15(7):630-5. doi:
10.1111/j.1442-2042.2008.02067.x. [PMID: 18479353]